Latest news
Canopy Growth's Recovery Story Collides With a Lingering Regulatory Shadow - AD HOC NEWSAD HOC NEWS · Mon, 10 Aug 2026 04:02:23 GMTIs Q2 Revenue Growth And Narrower Loss Altering The Investment Case For Ultragenyx Pharmaceutical (RARE)? - Yahoo! Finance CanadaYahoo! Finance Canada · Sun, 09 Aug 2026 22:16:37 GMTDoes OPKO Health’s Sharply Narrowed Q2 Loss Reset the Bull Case for OPKO Health (OPK)? - simplywall.stsimplywall.st · Sun, 09 Aug 2026 14:35:05 GMTFujishoji (TSE:6257) Stock Faces Dividend Strain Despite Narrower Losses - simplywall.stsimplywall.st · Sat, 08 Aug 2026 22:14:16 GMTRE MAX Holdings (RMAX) Stock Rises On Narrower Losses As Revenue Slips - simplywall.stsimplywall.st · Sat, 08 Aug 2026 06:16:04 GMTDürr (XTRA:DUE) Stock Caught Between Narrowing Losses And Fragile Profitability - simplywall.stsimplywall.st · Fri, 07 Aug 2026 19:50:26 GMTSnap (SNAP) Is Up 11.3% After Narrowing Losses And Highlighting AI Spectacles Potential Has The Bull Case Changed? - simplywall.stsimplywall.st · Fri, 07 Aug 2026 15:47:13 GMTHow Surging Revuforj and Niktimvo Sales and Narrowing Losses Could Shape Syndax Pharmaceuticals (SNDX) Investors - finance.yahoo.comfinance.yahoo.com · Fri, 07 Aug 2026 14:18:19 GMT